Erratum to “Predictors and Rates of Delayed Symptomatic Hyponatremia after Transsphenoidal Surgery: A Systematic Review” [World Neurosurg. 88 (2016) 1-6]

Coté, David J.; Alzarea, Abdulaziz Ibrahim; Acosta, Michael; Hulou, Mohamed Maher; Huang, Kevin T.; Almutairi, H.; Alharbi, Ahmad; Zaidi, Hasan A.; Algarni, Majed A.; Alatawi, Ahmed D.; Mekary, Rania A.; Smith, Timothy R.

doi:10.1016/j.wneu.2016.05.008

Cited by 4 publications

(3 citation statements)

References 0 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Complication rates decrease with increased experience of the neurosurgeon and are approximately for carotid artery injury, 0.4%; central nervous system injury, 0.6%; loss of vision, 0.5%; ophthalmoplegia, 0.4%; cerebrospinal fluid leak, 1.5%; meningitis, 0.5%; hypopituitarism, 7.2%; diabetes insipidus, 7.6%; death, 0.2% . Even with experienced neurosurgeons, delayed hyponatremia occurring 7 to 10 days postoperatively can occur in 4% to 10% of patients due to inappropriate vasopressin secretion …”

Section: Introductionmentioning

confidence: 99%

Diagnosis and Treatment of Pituitary Adenomas

Molitch

2017

JAMA

731

578

View full text Add to dashboard Cite

pproximately 10% of unselected pituitaries (meaning those from individuals without known pituitary disease) examined at autopsy contain pituitary adenomas. 1 Magnetic resonance imaging (MRI) scans of normal volunteers also show a 10% prevalence, 2 but other pathologic entities may have a similar appearance, such as Rathke cleft cysts and metastatic tumors. 3 Not all patients with pituitary tumors develop symptoms because most tumors remain small and most do not secrete hormones in excessive amounts. Clinical case-finding studies, in which all hospitals and practices in a geographic area were queried about cases with pituitary tumors over a defined period, have suggested a prevalence of pituitary adenoma ranging from 1 in 865 persons to 1 in 2688 persons (Table 1). 4,[6][7][8][9][10][11] Pituitary adenomas are classified into microadenomas (<10 mm), macroadenomas (Ն10 mm), and giant adenomas (Ն40 mm) (Figure 1). 12,13 Pituitary carcinomas with distant metastases are rare, occurring in 0.1% to 0.2% of cases. 12 If an MRI shows the tumor impinging on the optic chiasm, then formal visual field testing is indicated. 13 An evaluation for hypopituitarism should be carried out in all patients with macroadenomas and even large (6-9 mm) microadenomas. 1 Diabetes insipidus is rarely seen with pituitary adenomas. 1 About two-thirds of pituitary adenomas may secrete excess hormones. In the studies 4,6-11 that included 1718 patients, about 50% of cases were macroadenomas and 32% to 66% of tumors were secreting prolactin, 14% to 54% were clinically nonfunction-IMPORTANCE Pituitary adenomas may hypersecrete hormones or cause mass effects. Therefore, early diagnosis and treatment are important.OBSERVATIONS Prevalence of pituitary adenomas ranges from 1 in 865 adults to 1 in 2688 adults. Approximately 50% are microadenomas (<10 mm); the remainder are macroadenomas (Ն10 mm). Mass effects cause headache, hypopituitarism, and visual field defects. Treatments include transsphenoidal surgery, medical therapies, and radiotherapy. Prolactinomas account for 32% to 66% of adenomas and present with amenorrhea, loss of libido, galactorrhea, and infertility in women and loss of libido, erectile dysfunction, and infertility in men; they are generally treated with the dopamine agonists cabergoline and bromocriptine. Growth hormone-secreting tumors account for 8% to 16% of tumors and usually present with enlargement of the lips, tongue, nose, hands, and feet and are diagnosed by elevated insulin-like growth factor 1 levels and growth hormone levels; initial treatment is surgical. Medical therapy with somatostatin analogues, cabergoline, and pegvisomant is often also needed. Adrenocorticotropic hormone (ACTH)-secreting tumors account for 2% to 6% of adenomas and are associated with obesity, hypertension, diabetes, and other morbidity. Measurement of a late-night salivary cortisol level is the best screening test but petrosal sinus sampling for ACTH may be necessary to distinguish a pituitary from an ectopic source. The primary treatment of Cushin...

show abstract

Section: Introductionmentioning

confidence: 99%

Diagnosis and Treatment of Pituitary Adenomas

Molitch

2017

JAMA

731

578

View full text Add to dashboard Cite

show abstract

“…In a recent systematic review, the presence of permanent DI was not associated with the type of adenoma or its size. 14 Aulinas et al and Cote et al 3 18 found a higher rate of transient DI in patients with ACTH adenomas. Nayak et al 16 pointed out that transient DI occurred more frequently in patients with adenomas >4 cm and suprasellar extension.…”

Section: Discussionmentioning

confidence: 94%

Complication Rates after Endoscopic Transsphenoidal Surgery for ACTH-Secreting Pituitary Adenomas: A Comparative Analysis with GH and Nonfunctioning Adenomas

Aibar-Durán

Oladotun-Anka

Asencio-Cortés

et al. 2021

J Neurol Surg B Skull Base

View full text Add to dashboard Cite

Objectives Some complications have been more frequently reported after surgery for adrenocorticotropin hormone (ACTH)-secreting pituitary adenomas. We compared complication rates in patients with ACTH-secreting pituitary adenomas with those in patients with growth hormone secreting pituitary adenomas (growth hormone [GH] group) and nonfunctioning adenomas (nonfunctioning group). Design A comparative three-group analysis was performed for all patients who had endoscopic transsphenoidal surgery for pituitary adenomas at our center between January 2011 and May 2019. Variables included demographics, preoperative clinical and radiological characteristics, and postoperative radiological and endocrinological outcomes. Complications were divided into four categories: endocrinological, neurosurgical, medical, and ENT (ear–nose–throat)-related complications. Univariate and multivariate statistical analysis were performed. Results A total of 111 patients with pituitary adenomas and a mean age of 53.7 years were included (25 ACTH, 35 GH, and 51 nonfunctioning adenomas). Overall, 28 patients had microadenomas (25.2%) and 83 had macroadenomas (74.8%). Univariate statistical analysis for complications between groups showed no differences in neurosurgical and medical complications. Transient diabetes insipidus and postsurgical bacterial sinusitis were the only variables more frequently seen in the ACTH group (p = 0.01 and 0.04, respectively). Multivariate analysis for transient diabetes insipidus showed no differences between groups (p = 0.58). Conclusion Complication rates were similar in all three adenoma groups, particularly concerning major infections, thrombotic events, postoperative cerebrospinal fluid (CSF) leak, and transient diabetes insipidus. Transient diabetes insipidus was related with adenoma size and intraoperative CSF leak. Despite postoperative bacterial sinusitis was statistically higher in the ACTH group, this data should be interpreted with caution given the low number of patients with this complication.

show abstract

“…In contrast, J Hensen et al proposed that hyponatremia may be more closely associated with the pathological type of pituitary adenoma rather than age, adenoma size, and pituitary growth pattern [ 14 ]. David J Cote et al suggested that advanced age, female gender, macroadenomas, and ACTH adenomas were risk factors for delayed postoperative hyponatremia [ 15 ]. Arman Jahangiri posited a potential correlation between hyponatremia and preoperative pituitary hypofunction [ 16 ].…”

Section: Introductionmentioning

confidence: 99%

Gender potentially affects early postoperative hyponatremia in pituitary adenoma: XGBoost-based predictive modeling

Peng,

Li,

Wang

et al. 2024

Heliyon

View full text Add to dashboard Cite

Erratum to “Predictors and Rates of Delayed Symptomatic Hyponatremia after Transsphenoidal Surgery: A Systematic Review” [World Neurosurg. 88 (2016) 1-6]

Cited by 4 publications

References 0 publications

Diagnosis and Treatment of Pituitary Adenomas

Diagnosis and Treatment of Pituitary Adenomas

Complication Rates after Endoscopic Transsphenoidal Surgery for ACTH-Secreting Pituitary Adenomas: A Comparative Analysis with GH and Nonfunctioning Adenomas

Gender potentially affects early postoperative hyponatremia in pituitary adenoma: XGBoost-based predictive modeling

Contact Info

Product

Resources

About